Valeo Pharma Inc announced that its immune support product Hesperco is now available for sale at Loblaws stores across Canada.
The unique flavonoid formulation is being sold at 300 stores under the Loblaws banner, including Dominion, Zehrs, Fortinio's, Your Independent Grocer and Superstore.
Each Hesperco capsule contains 500mg of Valeo's unique hesperidin formulation and are available in bottles of 60 capsules. Hesperidin is a flavonoid with powerful antioxidant properties that help support the immune system.
READ: Valeo Pharma reveals a major milestone for its two innovative asthma therapies with reimbursements approved
A recent study confirmed hesperidin’s safety and potential benefits for the management of COVID-19 symptoms, according to Valeo.
Valeo CEO Steve Saviuk told investors that the company is encouraged by the results of the Hesperidin COVID-19 clinical trial, which has recently been submitted for publication.
“The study concluded that hesperidin could have beneficial effects and may help reduce certain COVID-19 symptoms,” Saviuk said in a statement. “The publication further suggested that earlier treatment of longer duration and/or higher dosage should be studied."
Valeo entered into a collaboration and licensing agreement with Ingenew Pharma Inc in April 2020 for the development, manufacture and commercialization of Hesperco.
Based in Kirkland, Quebec, Valeo Pharma is a pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on respirology, neurodegenerative diseases, oncology and other specialty products.
Contact Angela at angela@proactiveinvestors.com
Follow her on Twitter @AHarmantas